AP2220A - Pharmaceutical composition. - Google Patents
Pharmaceutical composition.Info
- Publication number
- AP2220A AP2220A APAP/P/2002/002507A AP2002002507A AP2220A AP 2220 A AP2220 A AP 2220A AP 2002002507 A AP2002002507 A AP 2002002507A AP 2220 A AP2220 A AP 2220A
- Authority
- AP
- ARIPO
- Prior art keywords
- pharmaceutical composition
- composition
- tablet
- aforegoing
- nevirapine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- NQDJXKOVJZTUJA-UHFFFAOYSA-N nevirapine Chemical compound C12=NC=CC=C2C(=O)NC=2C(C)=CC=NC=2N1C1CC1 NQDJXKOVJZTUJA-UHFFFAOYSA-N 0.000 abstract 2
- 229960001627 lamivudine Drugs 0.000 abstract 1
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 abstract 1
- 239000007942 layered tablet Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960000689 nevirapine Drugs 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 229960002555 zidovudine Drugs 0.000 abstract 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention discloses a pharmaceutical composition, which includes Lamivudine, Zidovudine and Nevirapine, or pharmaceutically acceptable derivatives of any of the aforegoing. The composition may be provided as a conventional tablet or as a bi-layered tablet.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200103831 | 2001-05-11 | ||
| ZA200103830 | 2001-05-11 | ||
| ZA200103832 | 2001-05-11 | ||
| ZA200103833 | 2001-05-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2002002507A0 AP2002002507A0 (en) | 2002-06-30 |
| AP2220A true AP2220A (en) | 2011-03-24 |
Family
ID=27506109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/2002/002507A AP2220A (en) | 2001-05-11 | 2002-05-10 | Pharmaceutical composition. |
Country Status (1)
| Country | Link |
|---|---|
| AP (1) | AP2220A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5627186A (en) * | 1991-05-16 | 1997-05-06 | Glaxo Group Limited | Antiviral combinations |
| US6417191B1 (en) * | 1995-03-30 | 2002-07-09 | Glaxosmithkline | Synergistic combinations of zidovudine, 1592U89 and 3TC |
-
2002
- 2002-05-10 AP APAP/P/2002/002507A patent/AP2220A/en active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5627186A (en) * | 1991-05-16 | 1997-05-06 | Glaxo Group Limited | Antiviral combinations |
| US6417191B1 (en) * | 1995-03-30 | 2002-07-09 | Glaxosmithkline | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Also Published As
| Publication number | Publication date |
|---|---|
| AP2002002507A0 (en) | 2002-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03006775A (en) | Pharmaceutical formulation. | |
| MXPA03007215A (en) | Pharmaceutical formulations. | |
| IL168266A (en) | Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments | |
| MXPA03007641A (en) | Pharmaceutical formulation. | |
| ZA200302039B (en) | Paclitaxel-based antitumor formulation. | |
| AU2003246810A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
| EP1450824A4 (en) | Pharmaceutical composition | |
| IL162200A (en) | 17a - ALKYL - 17?? - OXY - ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND INTERMEDIATES FOR THEIR PRODUCTION | |
| HUP0401898A3 (en) | 3-substituted-4-pyrimidone derivatives, pharmaceutical compositions containing them and their intermediates | |
| HUP0401900A3 (en) | 3-substituted-4-pyrimidone derivatives, pharmaceutical compositions containing them and their intermediates | |
| HUP0401638A3 (en) | Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same | |
| HUP0400200A3 (en) | Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AP2004003066A0 (en) | Pharmaceutical compositions based on azetidine derivatives. | |
| PL374761A1 (en) | N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them | |
| AU2002254077A1 (en) | Small molecule design against drug resistant mutants using directed evolution | |
| WO2005060981A3 (en) | Pharmaceutical compositions | |
| AP2220A (en) | Pharmaceutical composition. | |
| EP1389204A4 (en) | Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same | |
| ZA200408787B (en) | Pharmaceutical combination. | |
| MXPA03006162A (en) | Mikanolide derivatives, their preparation and therapeutic uses. | |
| ZA200110500B (en) | Pharmaceutical composition. | |
| WO2004092736A3 (en) | Derivatives of azithromycin | |
| MXPA03007318A (en) | Pharmaceutical composition. | |
| ZA200110501B (en) | Pharmaceutical composition. |